Advertisement
Life-Sciences-Asia.com
The East-West Life Sciences Web Portal
This is a free web portal for the life sciences in Asia-Pacific, Europe and North America... » read more
- Sciex and IonOpticks Announce LC-MS Co-Marketing Agreement (2024-10-25)
IonOpticks, a leading global producer of high-performance chromatography solutions and SCIEX a global leader in life science analytical technologies, announce a collaboration to co-market the Aurora Series XS range with the ZenoTOF line, including the latest ZenoTO... - Exclusive Interview with Stefan Miltenyi (by Georg Kääb) (2024-10-21)
With regard to biotechnology in Germany, various company names quickly come to mind, such as listed companies or those having raised large financing rounds. Since COVID, everyone knows the largest German biotech company, BioNTech SE in Mainz. If you take a long-tim... - Yumab and Molcure Partner for AI Ab Discovery Technology (2024-10-08)
YUMAB GmbH (“YUMAB”), a leading antibody discovery CRO headquartered in Braunschweig, Germany, and MOLCURE Inc. (“MOLCURE”), an AI-driven drug discovery company based in Kawasaki, Japan, announced their on-going collaboration now includes advancing the appl... - First Closing of Kurma Biofund IV at €140m; Targeting €250m (2024-10-03)
> Biofund IV raised EUR 140 million in first closing of EUR 250 million fund > Biofund IV to follow Kurma’s proven investment strategy and make 16 to 20 new investments > First three investments of the new fund already made > Landmark exits, strong financ... - Genentech Acquires CDK Inhibitors from Regor: $850m Upfront (2024-09-30)
Genentech will acquire Regor's next-generation CDK inhibitors for an upfront payment of $850 million in cash. Regor is also eligible to receive additional cash payments contingent on achieving future development, regulatory and commercial milestones Cambridge, M... - Tempus Expands Oncology Collaboration with Takeda (2024-09-26)
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announces an expansion to its collaboration with Takeda (TSE:4502/NYSE:TAK) that takes a data-first approach to research and develop... - Minaris Regenerative Medicine to Be Acquired by Altaris (2024-09-24)
Minaris Regenerative Medicine (“Minaris”), a leading cell therapy contract development and manufacturing organization, is pleased to announce that its parent company, Resonac Corporation (“Resonac”), has entered into a definitive agreement to sell Minaris t... - Launch of Aptadir Therapeutics to Develop RNA Inhibitors (2024-09-24)
> A novel approach for intractable cancers and genetic conditions > Science originates from 3 top international institutions – the Beth Israel Deaconess Medical Center of the Harvard Medical School, the Italian Research National Council (CNR) and the Cancer Sc... - Altaris to Acquire Minaris Regenerative from Resonac Corp (2024-09-24)
Resonac Corporation (President: Hidehito Takahashi, hereinafter called “REC”), announces that it has entered into a definitive share purchase agreement (hereinafter called “this deal”) to transfer all of the issued shares in Minaris Regenerative Medicine, L... - Symrise & Shan Foods Open Production Facility in Pakistan (2024-09-20)
> Ensures speed to market with the established local manufacturing footprint to Symrise key customers > To harness authentic and “hyperlocal” Pakistani flavours by embedding sustainability aspects > Collaboration with Shan Foods for innovation through cre...
Life-Sciences-Asia.com is your doorway to the East-West life sciences!
[LSA] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Asia-Pacific, Europe and North America regions.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Europe!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top